How Body Weight Affects Immune Response to COVID-19
Being overweight can impair the body’s antibody response to SARS-CoV-2 infection, but not to the protection offered by vaccination.
Being overweight can impair the body’s antibody response to SARS-CoV-2 infection, but not to the protection offered by vaccination.
The companies also filed an application with the FDA requesting approval of their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine for individuals 6 months of age and older.
Based on a study of more than 40,000 Canadians, researchers identified the personality type most inclined to resist or exhibit hesitancy toward receiving a COVID-19 vaccine.
Preliminary clinical testing has demonstrated that mRNA-1273.815 is effective in generating an immune response against the current XBB variants of concern.
Read MoreNew research reveals how cleaner air kills airborne viruses significantly quicker and why opening a window may be more important than originally thought.
Read MoreResearchers found that the increased rate of post-discharge arterial thromboembolism (ATE) was more than 27%, and those with cardiovascular disease were at even higher risk.
Read MorePfizer’s Paxlovid is the fourth drug—and first oral antiviral pill—approved by the FDA to treat COVID-19 in adults.
Read MoreNew research demonstrates the ability of a new respiratory responsive vocal biomarker machine-learning model to differentiate patients with COVID-19 from healthy individuals with about 70% accuracy.
Read MoreA new AACN Practice Alert summarizes expected clinical practice to reduce the risk of complications related to manual prone positioning.
Read MoreAs of April 15, the Arcturus variant, officially named XBB.1.6, comprised 7.2% of all US COVID cases, an increase from 3.9% a week prior.
Read MoreThe findings demonstrate that these drugs, which researchers say seem “very logical” from a mechanistic perspective, are not helpful in very sick patients with COVID-19 and should not be given.
Read MoreRT magazine spoke with manufacturers of inhaled nitric oxide delivery systems about the latest market innovations in the iNO industry, specifically about the impact of cylinder-free (“tankless”) systems, plus research on its potential use to treat other cardiopulmonary diseases.
Read MoreNatural immunity provides substantial protection against reinfection with COVID-19, according to research published in The Lancet, which found the risk of reinfection was 84% lower for those who had recovered from COVID-19 compared to those who had not been infected.
Read MoreResearchers say the new technology can enable rapid development of effective vaccines for bacterial diseases, including those caused by antibiotic-resistant bacteria.
Read MoreApproximately 11% of hospitalized COVID-19 patients had fibrotic patterning after recovery from acute illness, according to a new study from Imperial College London researchers published in AJRCCM.
Read More